Glutamine: indicated in cancer care?

Area of Science:

• Nutrition Science
• Oncology Support Care

Background:

• Glutamine is a nonessential amino acid abundant in dietary proteins.
• It plays crucial roles in immune function and intestinal health.
• In healthy individuals, dietary intake is typically sufficient.

Purpose of the Study:

• To evaluate the potential benefits of glutamine supplementation during cancer therapy.
• To explore the controversial role of glutamine as a conditionally essential amino acid in clinical settings.

Main Methods:

• Review of existing research on glutamine's effects in various clinical conditions.
• Analysis of studies investigating glutamine's efficacy as adjuvant therapy in cancer patients.

Main Results:

• Decreased glutamine levels are observed in patients with critical illness, post-surgery, and diseases like cancer, inflammatory bowel disease, and AIDS.
• Research on glutamine's benefits during cancer treatment shows encouraging but inconclusive results.
• The interpretation of data supporting glutamine supplementation in diverse clinical situations remains debated.

Conclusions:

• Glutamine may be conditionally essential in certain clinical conditions.
• Further research is necessary to confirm glutamine's mechanism of action and efficacy as adjuvant cancer therapy.